Home / Pharmaceutical company intelligence
CCL Pharmaceuticals (Pvt.) Limited logo
Pharmaceutical company intelligence

CCL Pharmaceuticals (Pvt.) Limited

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore-headquartered pharmaceutical and healthcare company with manufacturing operations and a multi-country commercial presence.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Jul 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
65, Quaid-e-Azam Industrial Estate, Kot Lakhpat, Lahore, Pakistan
Phone
+92 42 111 225 678
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000052 CCL Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000052 203 linked products · source seen 23 Sep 2026 View source ↗
DML 000891 39 linked products · source seen 23 Sep 2026 View source ↗
DSL 05-354-0077-068122D 14 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx256public portfolio records represented
REG196unique registrations represented
IDX77indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR231current validated price records
G99generic molecules in indexed catalogue
DF9dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage90%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixCCL Pharmaceuticals (Pvt.) LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Anti-infectives77 · 31%Hematology & thrombosis33 · 13%CNS & mental health32 · 13%Oncology & immunology29 · 12%Cardiovascular28 · 11%Vitamins, minerals & nutrition20 · 8%Gastrointestinal & hepatology15 · 6%Other therapeutic areas15 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioCCL Pharmaceuticals (Pvt.) LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026249presentationsTablet138 · 55%Injection44 · 18%Capsule25 · 10%Cream11 · 4%Syrup11 · 4%Suspension10 · 4%Other forms10 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionCCL Pharmaceuticals (Pvt.) LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026224comparable productsBelow peer median27 · 12%Near peer median73 · 33%Above peer median124 · 55%Company median price position+6.0%Lowest-price equivalents13Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsCCL Pharmaceuticals (Pvt.) LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,49 shared49% overlapGenome Pharmaceuticals (Pvt.) Ltd.45 shared45% overlapM/s. Genix Pharma (Pvt) Ltd.43 shared43% overlapPharmasol (Pvt) Ltd.43 shared43% overlapHIGH-Q Pharmaceuticals43 shared43% overlapBio-Labs(Pvt) Ltd41 shared41% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives77 products · 31%
Hematology & thrombosis33 products · 13%
CNS & mental health32 products · 13%
Oncology & immunology29 products · 12%
Cardiovascular28 products · 11%
Vitamins, minerals & nutrition20 products · 8%
Gastrointestinal & hepatology15 products · 6%
Endocrine & metabolic7 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antineoplastic medicines24 products · 10%
Antiepileptics22 products · 9%
Vitamins / minerals / hematinics20 products · 8%
Anticoagulants17 products · 7%
Third-generation cephalosporins15 products · 6%
Antifungals14 products · 6%
Antivirals13 products · 5%
Antiplatelet medicines10 products · 4%
Formulation footprint

Dosage forms

Tablet138 products
Injection44 products
Capsule25 products
Cream11 products
Syrup11 products
Suspension10 products
Infusion5 products
Lotion3 products
Other2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 EPICETAMLevetiracetam 11presentations 1000 mg, 250 mg, 500 mg, 500 mg/5 mL · Tablet, Injection #2 XALIARivaroxaban 10presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #3 CEF-ODCefixime 5presentations 100 mg/5 mL, 200 mg, 400 mg · Suspension, Tablet, Capsule #4 DASIROXDeferasirox 5presentations 100 mg, 250 mg, 400 mg, 500 mg · Tablet #5 LEUCOFOLATECalcium folinate (folinic acid) 5presentations 100 mg, 15 mg, 50 mg · Injection #6 TACGRAFTacrolimus 5presentations 0.5 mg, 1 mg, 5 mg · Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2712% of comparable products
Near market median73within ±5% of median
Above market median12455% of comparable products
Lowest-price equivalents13ties included
Company median price position +6.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
TEGREY 100 mg/5 mLCarbamazepine · Suspension · 120ml PKR 0.81/mL-54.4% vs market median METOMIDE 10 mgMetoclopramide · Tablet · 20's PKR 1.04/tablet-53.9% vs market median Leukozole 150 mgFluconazole · Capsule · 1's PKR 135.06/capsule-48.8% vs market median Leukozole 150 mgFluconazole · Capsule · 2's PKR 135.06/capsule-48.8% vs market median STIVANT 400 mg/16 mLBevacizumab · Concentrate for solution for infusion · 1's PKR 102,238.25/vial/unit-44.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 49shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 45shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 43shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 43shared generics HIGH-Q Pharmaceuticals215 products · 61 generics 43shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 41shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers191Distinct registrations among indexed, published, presentation-validated products only
Verified price observations249
Products with a verified price249
Products with multiple price observations0
Source records with multiple versions249
Latest portfolio source check22 Sep 2026
Latest effective price date23 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

196 unique registration(s) · 77 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
ABRIVA Sofosbuvir 400 mg Tablet 28's 080087 PKR 12,119.20 PKR 432.83/tablet Near median
ABRIVA PLUS Sofosbuvir + Velpatasvir 400 mg + 100 mg Tablet 28's 091781 PKR 19,821.25 PKR 707.90/tablet Near median
ACASIA Azithromycin 250 mg Capsule 6's 028731 PKR 418.76 PKR 69.79/capsule 41% above median
ACASIA Azithromycin 250 mg Capsule 10's 028731 PKR 684.68 PKR 68.47/capsule 39% above median
BACTCID Ciprofloxacin 100 mg Injection 50 ml 024924 PKR 456.79 PKR 9.14/mL No comparator
BACTCID Ciprofloxacin 250 mg Tablet 10's 025572 PKR 368.00 PKR 36.80/tablet 46% above median
BACTCID Ciprofloxacin 500 mg Tablet 10's 025573 PKR 647.68 PKR 64.77/tablet 51% above median
BACTCID Ciprofloxacin 250 mg/5 mL Suspension 60ml 074282 PKR 330.45 PKR 5.51/mL 7% above median
CEF-OD Cefixime 100 mg/5 mL Suspension 60ml 033949 PKR 619.59 PKR 10.33/mL Near median
CEF-OD Cefixime 100 mg/5 mL Suspension 30ml 033949 PKR 330.39 PKR 11.01/mL Near median
CEF-OD Cefixime 400 mg Capsule 5's 034756 PKR 592.03 PKR 118.41/capsule Near median
CEF-OD Cefixime 200 mg Tablet 5's 052703 PKR 325.12 PKR 65.02/tablet Near median
CEF-OD Cefixime 200 mg Tablet 10's 052703 PKR 618.73 PKR 61.87/tablet Near median
CEF-OD DS Cefixime 200 mg/5 mL Suspension 60 ml 052704 PKR 792.46 PKR 13.21/mL Near median
CEF-OD DS Cefixime 200 mg/5 mL Suspension 30 ml 052704 PKR 404.33 PKR 13.48/mL Near median
CEFTORINGE Cefotaxime 250 mg Injection Vial 016077 PKR 110.89 PKR 110.89/vial/unit 5% above median
CEFTORINGE Cefotaxime 1 g Injection Vial 016078 PKR 300.57 PKR 300.57/vial/unit Near median
CEFTORINGE Cefotaxime 500 mg Injection Vial 046329 PKR 170.61 PKR 170.61/vial/unit 7% above median
CLYSO Cycloserine 250 mg Capsule 10's 060558 PKR 1,469.00 PKR 146.90/capsule Near median
COMBIVIRIN Lamivudine + Zidovudine 150 mg + 300 mg Tablet 60's 040601 PKR 6,195.91 PKR 103.27/tablet Near median
COMBIVIRIN Lamivudine + Zidovudine 150 mg + 300 mg Tablet 20's 040601 PKR 2,065.31 PKR 103.27/tablet Near median
COMBIVIRIN Lamivudine + Zidovudine 150 mg + 300 mg Tablet 30's 040601 PKR 3,097.96 PKR 103.27/tablet Near median
Dynaclo Clotrimazole 1% Lotion 30ml 098354 PKR 72.97 PKR 2.43/mL 27% above median
Dynamycin Azithromycin 250 mg Capsule 6's 104641 PKR 314.07 PKR 52.35/capsule 6% above median
Dynamycin Azithromycin 250 mg Tablet 6's 107057 PKR 324.34 PKR 54.06/tablet 15% above median
Dynamycin Azithromycin 500 mg Tablet 6's 108026 PKR 594.62 PKR 99.10/tablet 17% above median
Dynarix Permethrin 5% Cream 30gm 096612 PKR 102.90 PKR 3.43/g 12% below median
Dynarix Permethrin 5% Cream 60ml 099996 PKR 165.22 PKR 2.75/mL Near median
Dynasil Terbinafine 1 % Cream 10gm 096615 PKR 332.99 PKR 33.30/g 15% above median
Dynatrim Clotrimazole 1% Cream 15gm 095442 PKR 96.93 PKR 6.46/g 14% above median
Dynatrim Clotrimazole 10% Cream 5gm 095443 PKR 142.65 PKR 28.53/g Near median
Dynatrim Extra Clotrimazole + Hydrocortisone 1% + 1% Cream 10gm 095444 PKR 127.96 PKR 12.80/g Near median
Dynazin Sulphadiazine 1% Cream 50gm 096613 PKR 256.27 PKR 5.13/g 10% above median
Dynazin Sulphadiazine 1 % Cream 250gm 096613 PKR 769.07 PKR 3.08/g 23% below median
Dynazin Sulphadiazine 1% Cream 15gm 096613 PKR 87.37 PKR 5.82/g 25% above median
Dynazin Sulphadiazine 1 % Cream 20gm 096613 PKR 116.48 PKR 5.82/g 89% above median
HONGOS Voriconazole 200 mg/5 mL Oral suspension 60ml 077021 PKR 2,854.11 PKR 47.57/mL 17% above median
Leukozole Fluconazole 50 mg Capsule 7's 096600 PKR 873.66 PKR 124.81/capsule Near median
Leukozole Fluconazole 150 mg Capsule 2's 106311 PKR 270.12 PKR 135.06/capsule 49% below median
Leukozole Fluconazole 150 mg Capsule 1's 106311 PKR 135.06 PKR 135.06/capsule 49% below median
LEVOCIL Levofloxacin 250 mg Tablet 10's 023985 PKR 610.61 PKR 61.06/tablet 27% above median
LEVOCIL Levofloxacin 500 mg Tablet 10's 029542 PKR 801.42 PKR 80.14/tablet Near median
MALGO Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 042711 PKR 660.90 PKR 41.31/tablet 5% above median
MALGO Artemether 80 mg Injection 6-Amps 042713 PKR 1,213.93 — No comparator
MALGO Artemether 80 mg Injection 1's 042713 PKR 202.32 PKR 202.32/vial/unit Near median
MALGO Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 054134 PKR 551.57 PKR 68.95/tablet 8% above median
MALGO Artemether 40 mg Injection 1mlx10's 068118 PKR 1,253.56 PKR 125.36/mL 13% above median
MALGO 80/480 Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 057695 PKR 689.46 PKR 114.91/tablet 5% above median
MALGO 80/480 Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 057695 PKR 459.64 PKR 114.91/tablet 5% above median
MAXIVIR Lamivudine 100 mg Tablet 14's 029953 PKR 1,950.84 PKR 139.35/tablet 146% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). CCL Pharmaceuticals (Pvt.) Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/ccl-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.